Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 66

1.

Efficacy and safety of maraviroc vs. efavirenz in treatment-naive patients with HIV-1: 5-year findings.

Cooper DA, Heera J, Ive P, Botes M, Dejesus E, Burnside R, Clumeck N, Walmsley S, Lazzarin A, Mukwaya G, Saag M, van Der Ryst E.

AIDS. 2014 Mar 13;28(5):717-25. doi: 10.1097/QAD.0000000000000131.

PMID:
24983542
[PubMed - in process]
Free PMC Article
2.

Recent developments in hiv treatment and their dissemination in poor countries.

Ebrahim O, Mazanderani AH.

Infect Dis Rep. 2013 Jun 6;5(Suppl 1):e2. doi: 10.4081/idr.2013.s1.e2. eCollection 2013 Jun 6. Review.

PMID:
24470966
[PubMed]
Free PMC Article
3.

HIV-1 tropism testing in subjects achieving undetectable HIV-1 RNA: diagnostic accuracy, viral evolution and compartmentalization.

Pou C, Codoñer FM, Thielen A, Bellido R, Pérez-Álvarez S, Cabrera C, Dalmau J, Curriu M, Lie Y, Noguera-Julian M, Puig J, Martínez-Picado J, Blanco J, Coakley E, Däumer M, Clotet B, Paredes R.

PLoS One. 2013 Aug 1;8(8):e67085. doi: 10.1371/journal.pone.0067085. Print 2013.

PMID:
23936293
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Structure and dynamics of the gp120 V3 loop that confers noncompetitive resistance in R5 HIV-1(JR-FL) to maraviroc.

Yuan Y, Yokoyama M, Maeda Y, Terasawa H, Harada S, Sato H, Yusa K.

PLoS One. 2013 Jun 28;8(6):e65115. doi: 10.1371/journal.pone.0065115. Print 2013.

PMID:
23840315
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

A common mechanism of clinical HIV-1 resistance to the CCR5 antagonist maraviroc despite divergent resistance levels and lack of common gp120 resistance mutations.

Roche M, Salimi H, Duncan R, Wilkinson BL, Chikere K, Moore MS, Webb NE, Zappi H, Sterjovski J, Flynn JK, Ellett A, Gray LR, Lee B, Jubb B, Westby M, Ramsland PA, Lewin SR, Payne RJ, Churchill MJ, Gorry PR.

Retrovirology. 2013 Apr 20;10:43. doi: 10.1186/1742-4690-10-43.

PMID:
23602046
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Mucosal transmissibility, disease induction and coreceptor switching of R5 SHIVSF162P3N molecular clones in rhesus macaques.

Ren W, Mumbauer A, Zhuang K, Harbison C, Knight H, Westmoreland S, Gettie A, Blanchard J, Cheng-Mayer C.

Retrovirology. 2013 Jan 31;10:9. doi: 10.1186/1742-4690-10-9.

PMID:
23369442
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Escape from human immunodeficiency virus type 1 (HIV-1) entry inhibitors.

De Feo CJ, Weiss CD.

Viruses. 2012 Dec;4(12):3859-911. Review.

PMID:
23342377
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Transmitted/founder and chronic HIV-1 envelope proteins are distinguished by differential utilization of CCR5.

Parker ZF, Iyer SS, Wilen CB, Parrish NF, Chikere KC, Lee FH, Didigu CA, Berro R, Klasse PJ, Lee B, Moore JP, Shaw GM, Hahn BH, Doms RW.

J Virol. 2013 Mar;87(5):2401-11. doi: 10.1128/JVI.02964-12. Epub 2012 Dec 26.

PMID:
23269796
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Identification of interdependent variables that influence coreceptor switch in R5 SHIV(SF162P3N)-infected macaques.

Zhuang K, Finzi A, Toma J, Frantzell A, Huang W, Sodroski J, Cheng-Mayer C.

Retrovirology. 2012 Dec 13;9:106. doi: 10.1186/1742-4690-9-106.

PMID:
23237529
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

HIV infection, aging, and immune function: implications for cancer risk and prevention.

Dubrow R, Silverberg MJ, Park LS, Crothers K, Justice AC.

Curr Opin Oncol. 2012 Sep;24(5):506-16. Review.

PMID:
22759737
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Vicriviroc resistance decay and relative replicative fitness in HIV-1 clinical isolates under sequential drug selection pressures.

Tsibris AM, Hu Z, Paredes R, Leopold KE, Putcharoen O, Schure AL, Mazur N, Coakley E, Su Z, Gulick RM, Kuritzkes DR.

J Virol. 2012 Jun;86(12):6416-26. doi: 10.1128/JVI.00286-12. Epub 2012 Apr 4.

PMID:
22491471
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Differential use of CCR5 by HIV-1 clinical isolates resistant to small-molecule CCR5 antagonists.

Henrich TJ, Lewine NR, Lee SH, Rao SS, Berro R, Gulick RM, Moore JP, Tsibris AM, Kuritzkes DR.

Antimicrob Agents Chemother. 2012 Apr;56(4):1931-5. doi: 10.1128/AAC.06061-11. Epub 2012 Jan 17.

PMID:
22252820
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Drug resistance in HIV-1.

Kuritzkes DR.

Curr Opin Virol. 2011 Dec;1(6):582-9. doi: 10.1016/j.coviro.2011.10.020. Review.

PMID:
22162985
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Canadian consensus guidelines for the optimal use of maraviroc in the treatment of HIV-infected adults.

Rachlis A, Harris M, Lalonde R, Shafran SD, Tremblay C, Wainberg MA, Walmsley S.

Can J Infect Dis Med Microbiol. 2010 Winter;21(4):159-72.

PMID:
22132003
[PubMed]
Free PMC Article
15.

HIV-1 clinical isolates resistant to CCR5 antagonists exhibit delayed entry kinetics that are corrected in the presence of drug.

Putcharoen O, Lee SH, Henrich TJ, Hu Z, Vanichanan J, Coakley E, Greaves W, Gulick RM, Kuritzkes DR, Tsibris AM.

J Virol. 2012 Jan;86(2):1119-28. doi: 10.1128/JVI.06421-11. Epub 2011 Nov 16.

PMID:
22090117
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

CCR5 blockade is well tolerated and induces changes in the tissue distribution of CCR5+ and CD25+ T cells in healthy, SIV-uninfected rhesus macaques.

Taaffe JE, Bosinger SE, Del Prete GQ, Else JG, Ratcliffe S, Ward CD, Migone T, Paiardini M, Silvestri G.

J Med Primatol. 2012 Feb;41(1):24-42. doi: 10.1111/j.1600-0684.2011.00521.x. Epub 2011 Nov 14.

PMID:
22077380
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

CCR5 antagonism in HIV infection: current concepts and future opportunities.

Wilkin TJ, Gulick RM.

Annu Rev Med. 2012;63:81-93. doi: 10.1146/annurev-med-052010-145454. Epub 2011 Oct 27. Review.

PMID:
22034870
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

CCR5 inhibitors: Emerging promising HIV therapeutic strategy.

Rao PK.

Indian J Sex Transm Dis. 2009 Jan;30(1):1-9. doi: 10.4103/0253-7184.55471.

PMID:
21938106
[PubMed]
Free PMC Article
19.

Inhibition of HIV transmission in human cervicovaginal explants and humanized mice using CD4 aptamer-siRNA chimeras.

Wheeler LA, Trifonova R, Vrbanac V, Basar E, McKernan S, Xu Z, Seung E, Deruaz M, Dudek T, Einarsson JI, Yang L, Allen TM, Luster AD, Tager AM, Dykxhoorn DM, Lieberman J.

J Clin Invest. 2011 Jun;121(6):2401-12. doi: 10.1172/JCI45876. Epub 2011 May 16.

PMID:
21576818
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Reanalysis of coreceptor tropism in HIV-1-infected adults using a phenotypic assay with enhanced sensitivity.

Wilkin TJ, Goetz MB, Leduc R, Skowron G, Su Z, Chan ES, Heera J, Chapman D, Spritzler J, Reeves JD, Gulick RM, Coakley E.

Clin Infect Dis. 2011 Apr 1;52(7):925-8. doi: 10.1093/cid/cir072.

PMID:
21427401
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk